This inventor holds 1 USPTO granted patent. Top assignee: Denali Therapeutics Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Dana Andersen: Innovator in Protein Molecule Formulations
Introduction
Dana Andersen is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of protein molecule formulations. His innovative work has led to the development of a patent that addresses important biochemical challenges.
Latest Patents
Dana Andersen holds a patent titled "Formulations of Protein Molecules Comprising Iduronate 2-Sulfatase." This patent represents his commitment to advancing scientific knowledge and improving therapeutic options in the medical field. He has 1 patent to his name, showcasing his expertise and dedication to innovation.
Career Highlights
Dana is currently employed at Denali Therapeutics Inc., a company focused on developing therapies for neurodegenerative diseases. His role at Denali Therapeutics allows him to work at the forefront of scientific research and development. His contributions are vital to the company's mission of creating effective treatments for patients.
Collaborations
Dana collaborates with talented individuals such as Tina Giese and Adam Catherman. These partnerships enhance the innovative environment at Denali Therapeutics and contribute to the success of their projects.
Conclusion
Dana Andersen is a distinguished inventor whose work in protein molecule formulations has the potential to impact the medical field significantly. His dedication to innovation and collaboration with skilled colleagues positions him as a key player in advancing therapeutic solutions.